Analyst Ranking
Top 24%
#1119 out of 4792 analysts
Average Return
+2.31%
Win Rate
46%73 out of 158
Risk vs Reward
Poor
Good

Shagun Singh's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Penumbra IncPEN
+158.98%$121.05$313.49
2022-07-18 -
2023-07-17
Buy
Intuitive Surgical IncISRG
+95.25%$266.91$521.15
2023-10-20 -
2024-10-18
Buy
Intuitive Surgical IncISRG
+65.12%$290.08$478.98
2023-08-17 -
2024-08-16
Buy
Boston Scientific CorpBSX
+60.81%$60.25$96.89
2024-01-16 -
2025-01-15
Buy
Intuitive Surgical IncISRG
+60.14%$370.07$592.64
2024-01-24 -
2025-01-17
Buy

Shagun Singh Analyst Color

Get additional color on Shagun Singh's coverage of popular stocks

Shagun Singh's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Stryker CorpSYK
17Buy$425.00+10.84%Reiterates
12 days ago
Outset Medical IncOM
9Hold$3.00+279.75%Reiterates
12 days ago
Edwards Lifesciences CorpEW
18Buy$85.00+21.81%Maintains
a month ago
Nevro CorpNVRO
9Hold$7.00+53.17%Reiterates
2 months ago
Globus Medical IncGMED
5Buy$92.00+1.32%Maintains
2 months ago
Inspire Medical Systems IncINSP
3Buy$260.00+46.33%Reiterates
2 months ago
Zimmer Biomet Holdings IncZBH
11Buy$125.00+14.09%Maintains
2 months ago
Teleflex IncTFX
18Buy$245.00+35.16%Maintains
3 months ago
Dexcom IncDXCM
4Buy$115.00+36.29%Maintains
3 months ago
Boston Scientific CorpBSX
13Buy$98.00-0.67%Maintains
3 months ago
Intuitive Surgical IncISRG
13Buy$555.00-6.35%Maintains
3 months ago
Johnson & JohnsonJNJ
15Buy$181.00+23.10%Maintains
3 months ago
Medtronic PLCMDT
17Buy$105.00+19.21%Upgrades
3 months ago
Zynex IncZYXI
5Buy$11.00+43.23%Maintains
3 months ago
Penumbra IncPEN
9Buy$222.00-15.81%Maintains
3 months ago
Abbott LaboratoriesABT
10Buy$130.00+14.56%Maintains
3 months ago
Tandem Diabetes Care IncTNDM
1Buy$65.00+84.92%Initiates Coverage On
4 months ago
Axonics IncAXNX
5Hold$71.00+0.03%Reiterates
a year ago
Nuvasive IncNUVA
4Buy$58.00N/AReiterates
2 years ago
Seaspine Holdings CorpSPNE
1Strong Buy$24.00N/AUpgrades
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.